Fresenius Med ADS (FMS) Posts Q3 EPS of $0.76, Tops Street by 1c; Guides
More News related to FMS
- Fresenius Medical Care North America Acquires Health IT Services Group, Acumen nEHR
- Fresenius Med ADS (FMS) Posts Q3 EPS of $0.76, Tops Street by 1c; Guides
- Fresenius Medical Care Reports Strong Third Quarter and Nine Months Results; Improved Guidance for 2009
- Trading Overview for MedaSorb Technologies Corp. Issued by StockPreacher.com
- Don't Miss Out! Two Weeks Left to Register for the 2010 IR Global Rankings
Fresenius Med ADS (NYSE: FMS) reports Q3 EPS of $0.76, 1 cent better than the analyst estimate of $0.75. Revenue for the quarter was $2.89 billion, which compares to the estimate of $2.84 billion.
Sees FY09 revs of $11.20 billion, up from $11.10 billion previously. Consensus sees $11.13 billion.
Related Categories
EarningsGuidance
Stocks Mentioned
-0.98Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
